We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Bionostics | BIO | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 29.75 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 29.75 |
| Top Posts |
|---|
Posted at 28/11/2012 22:20 by moneymunch none of the following UK Bio's are listed (yet), but could be worth watching....????4 November 2012 £39m Biomedical Catalyst funding will speed-up development of new healthcare technologies Grants from the government-backed Biomedical Catalyst totalling £39 million have been awarded to 32 projects led by small and medium-sized businesses (SMEs) and universities to accelerate the development of innovative solutions to healthcare challenges. The 22 business-led projects will be managed by: Arecor Ltd, Bioinduction Ltd, Cantab Biopharmaceuticals Ltd, Creabilis Ltd, Cyclacel Ltd, Discuva Ltd, ELISHA Systems Ltd, Glide Pharmaceutical Technologies Ltd, ImmunoBiology Ltd, Immunocore Ltd, Intelligent Fingerprinting Ltd, IXICO Ltd, Kalvista Pharmaceuticals Ltd, Medical Research Council Technology, Modern Biosciences plc, OJ-Bio Ltd, Pharminox Ltd, Prosonix Ltd, PsiOxus Therapeutics Ltd, QuantuMDx Group Ltd, Sentinel Oncology Ltd and UB Pharma. |
Posted at 21/11/2009 22:57 by theape2 a site for my favourite bullish biotech charts. all suggestions welcome (Bio sector, break above the 200d ma on good volume, preferably low cap and cash for 6 months). and ill post them upin the meantime back to what a good thread is all about. buffoonery, making money, and pratting about |
Posted at 28/12/2007 09:08 by vlain So if one share in BIO is equivalent to 1 NAV Bidco, what is 1 NAV Bidco share worth? Is it 30p!!!!Also, 1 NAV Bidco share consists of 1 NAV Bidco ordinary share and 1 NAV Bidco preference share, what does that mean in terms of value??? |
Posted at 06/12/2007 12:00 by tommya Great news for shareholders but what should they do now?Price seems to have stabilised at 28p, with a sell price available at 27.5p, i.e. around 8% below the 30p offer. Should holders: i) sell. ii) hold The following outlines the timetable from this morning's RNS: "15.2 Anticipated Timetable Bionostics anticipates that it will despatch the Scheme Document to Bionostics Shareholders and, for information only, to holders of options granted under the Bionostics Share Schemes on or about 15 December 2007, but in any event within the next 28 days (or such later date as may be agreed with the Panel); that the Court Meeting and EGM will take place during January 2008; and subject to the Scheme becoming unconditional and effective in accordance with its terms, the Effective Date will occur at the end of January 2008. The timing of events which relate to the implementation of the Scheme is, however, subject to the approval of the Court and is therefore subject to change. A full anticipated timetable will be set out in the Scheme Document. If the Proposals do not become effective by 29 February 2008, the Proposals will lapse except where the approval of Bionostics Shareholders at the Court Meeting and the EGM is obtained before this date, in which case the longstop date for the Proposals may be extended to such later date as NAV Bidco and Bionostics may agree and, if appropriate, the Court may approve." The market is discounting 8% of value due to the uncertainty of the deal going through between now and end February; i.e. attributing an 8% chance of it fallling through. All Bio directors have signed up to the proposal, as have NAV and Mannheim Holdings, who have 10.3% of share capital. Mannheim have stated that their "irrevocable undertaking will only lapse if a competing offer is made for the entire issued share capital of Bionostics which exceeds the value of the Offer by ten per cent. or more." So, what chance a counterbid by a third party? |
Posted at 04/12/2007 17:47 by aquilla This share never ceases to amaze. It is on the radar of only a few investors, ignored by the rest. In some ways not surprising, with a market cap of a mere £7m and a chart that looks horrendous. Indeed it has never caught the imagination in the way that some small caps have (remember RTD?). When I started the first BIO thread (and I originally got in back in January at 23p) there would be a couple of posts a week, if that. But what is surprising is that the share price is now languishing at 14.5p, given the fact that there are still ongoing talks which might lead to an offer of 30p and that, aside from the bid element, the fundamentals of the company offer hope for the future. With a new CEO with a turn-around track record brought in last year, the loss making divisions gone and two cash generative divisions left one would have expected the share price to have done more. Yes, there is the debt but, as has been pointed out before, hopefully the cash generative divisions will reduce this sharply. Part of the problem lies, I believe, with the illiquidity of the share. A small cap already, most of the shares are held by institutions. NMS at the moment is 1500, and 5000 traded today would have cleared the order book. A pathetic amount. I have indeed found that it can be traded in much larger quantities, without moving the share price against the trader, but how many private investors have the knowledge or persuasive powers to go down that route? Is this going to turn out to have been a good investment? Time will tell, but in the meantime we remain in the doldrums. |
Posted at 28/11/2007 13:29 by vlain The link shows that there has been no trade on BIO today.....significan |
Posted at 28/11/2007 12:57 by imout Thanks marbles, your link not working but found bio on:I am a bit thick I know, but what is the point of an LSE-quoted spread that bears no relation to reality? |
Posted at 28/11/2007 12:38 by imout If I may butt in, I have been trying to top up with 5,000 this morning at the supposed offer price of 14.5p, but keep getting quoted 15.99p. Low quantity I know, but I have not seen this "wider than advertised" spread on previous BIO purchases. What conclusion do any of you draw from that? |
Posted at 21/11/2007 18:37 by knowing Just tell me why I should look at this? Chart looks terriblewilliam47 - 21 Nov'07 - 16:22 - 1999 of 2001 GUYS TAKE A LOOK AT bio/bionostics |
Posted at 12/11/2007 10:12 by tunturiflyer Hopefully half year results will be good, and should be due sometime in the next couple of weeks. Theoretically, BIO is worth a lot more just on fundamentals. This is because there should be six months of operating with just 2 divisions. If I recall correctly, for last half years' results they divested a company, and the IVD division results were shafted by 1 customer moving to VMI, (and so didn't buy anything for a couple months) and another customer's new product didn't take off quite as fast as expected. So the last half year results were quite unclear. So all I want is something over 1p EPS, and decent cash flow to pay down the debt. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
